assess-special-population-strategylisted

Assesses the completeness and internal consistency of a programme's special-population evidence strategy — renal impairment, hepatic impairment, paediatrics, pregnancy and lactation, elderly, and other defined sub-populations — against the programme's declared scope, the target product profile, and the guidance-anchored criteria that create study or analysis obligations for each population. Use this skill when someone asks whether the special-population strategy covers what a reviewer will expect, which populations still need characterisation, or whether the strategy documents are internally consistent. Example: "Please the special-population strategy covers what a reviewer will expect, which populations still need characterisation." Do not use for reviewing one organ-impairment study report, for demographic covariate assessment in a PopPK, for pharmacogenomic characterisation, or for any request to decide whether a waiver rationale is sufficient or to commit to a study.
malekokour/clinpharm-pmx-skills · ★ 6 · Data & Documents · score 77

Install: claude install-skill malekokour/clinpharm-pmx-skills

# Special Population Strategy Assessment Assess a programme's special-population evidence strategy for completeness, internal consistency, and traceability to the criteria that create each obligation. Cover renal impairment, hepatic impairment, paediatrics, pregnancy and lactation, elderly, and any other population the programme's scope declares — each mapped to whether it is addressed by a dedicated study, a PopPK covariate analysis, a model-based approach, a written waiver rationale, or nothing. **This skill assesses the strategy. It never decides that a waiver is sufficient, commits to a study, selects a dose for a special population, or determines that characterisation is adequate for filing.** ## Who this is for Clinical pharmacology leads owning a programme's special-population strategy · CP reviewers preparing for a pre-NDA or Type C meeting · regulatory strategists checking that the strategy matches what the evidence expectations demand for each population. ## When to use this skill - "Does our special-population strategy cover what a reviewer will expect?" - "Which populations still need characterisation before we file?" - "Is our paediatric plan consistent with what we told the agency?" - "Map every special population to whether we have a study, a PopPK analysis, a waiver, or nothing" - "Are the renal and hepatic strategies internally consistent with the dose-modification rules?" ## When NOT to use this skill | Request | Why not this skill | Where it belongs